APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticoagulants Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anticoagulants Drug Industry Growth and Trends Forecast to 2032

19 December 2025107 pages

Choose your research edition.

Industry ResearchAnticoagulants Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticoagulants Drug Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Anticoagulants Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticoagulants Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticoagulants Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anticoagulants Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anticoagulants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anticoagulants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anticoagulants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anticoagulants Drug include Alere (US), Bristol-Myers Squibb (US), C. H. Boehringer Sohn (Germany), CoaguSense (US), Daiichi Sankyo (Japan), Portola Pharmaceuticals (US), Pfizer (US), Roche (Switzerland) and Johnson & Johnson (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anticoagulants Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anticoagulants Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anticoagulants Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anticoagulants Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anticoagulants Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anticoagulants Drug Market by Company

Alere (US)

Bristol-Myers Squibb (US)

C. H. Boehringer Sohn (Germany)

CoaguSense (US)

Daiichi Sankyo (Japan)

Portola Pharmaceuticals (US)

Pfizer (US)

Roche (Switzerland)

Johnson & Johnson (US)

Siemens (Germany)

Abbott (US)

Anticoagulants Drug Segment by Type

Novel Oral Anticoagulants (NOACs)

Warfarin (VKA)

Others

Anticoagulants Drug Segment by Application

Hospital

Clinic

Others

Anticoagulants Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anticoagulants Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anticoagulants Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Novel Oral Anticoagulants (NOACs) Table 2. Major Company of Warfarin (VKA) Table 3. Major Company of Others Table 4. Global Anticoagulants Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anticoagulants Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Anticoagulants Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anticoagulants Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anticoagulants Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Anticoagulants Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Anticoagulants Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Anticoagulants Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anticoagulants Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anticoagulants Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Anticoagulants Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Anticoagulants Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Anticoagulants Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anticoagulants Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Anticoagulants Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anticoagulants Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Anticoagulants Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anticoagulants Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Anticoagulants Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anticoagulants Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Anticoagulants Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Anticoagulants Drug Industry Trends Table 26. Anticoagulants Drug Industry Drivers Table 27. Anticoagulants Drug Industry Opportunities and Challenges Table 28. Anticoagulants Drug Industry Restraints Table 29. Global Anticoagulants Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anticoagulants Drug Revenue Market Share by Company (2021-2026) Table 31. Global Anticoagulants Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Anticoagulants Drug Sales Share by Company (2021-2026) Table 33. Global Anticoagulants Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Anticoagulants Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anticoagulants Drug Major Company Production Sites and Headquarters Table 36. Global Anticoagulants Drug Company, Product Type & Application Table 37. Global Anticoagulants Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anticoagulants Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anticoagulants Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anticoagulants Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Anticoagulants Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anticoagulants Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anticoagulants Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Anticoagulants Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Anticoagulants Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Anticoagulants Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anticoagulants Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anticoagulants Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Anticoagulants Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Anticoagulants Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anticoagulants Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Anticoagulants Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anticoagulants Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anticoagulants Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Anticoagulants Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Anticoagulants Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Anticoagulants Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anticoagulants Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anticoagulants Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Anticoagulants Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Anticoagulants Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Anticoagulants Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anticoagulants Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Anticoagulants Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anticoagulants Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Anticoagulants Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anticoagulants Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Anticoagulants Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anticoagulants Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Anticoagulants Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Alere (US) Company Information Table 73. Alere (US) Business Overview Table 74. Alere (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Alere (US) Anticoagulants Drug Product Portfolio Table 76. Alere (US) Recent Development Table 77. Bristol-Myers Squibb (US) Company Information Table 78. Bristol-Myers Squibb (US) Business Overview Table 79. Bristol-Myers Squibb (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bristol-Myers Squibb (US) Anticoagulants Drug Product Portfolio Table 81. Bristol-Myers Squibb (US) Recent Development Table 82. C. H. Boehringer Sohn (Germany) Company Information Table 83. C. H. Boehringer Sohn (Germany) Business Overview Table 84. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product Portfolio Table 86. C. H. Boehringer Sohn (Germany) Recent Development Table 87. CoaguSense (US) Company Information Table 88. CoaguSense (US) Business Overview Table 89. CoaguSense (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CoaguSense (US) Anticoagulants Drug Product Portfolio Table 91. CoaguSense (US) Recent Development Table 92. Daiichi Sankyo (Japan) Company Information Table 93. Daiichi Sankyo (Japan) Business Overview Table 94. Daiichi Sankyo (Japan) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Daiichi Sankyo (Japan) Anticoagulants Drug Product Portfolio Table 96. Daiichi Sankyo (Japan) Recent Development Table 97. Portola Pharmaceuticals (US) Company Information Table 98. Portola Pharmaceuticals (US) Business Overview Table 99. Portola Pharmaceuticals (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Portola Pharmaceuticals (US) Anticoagulants Drug Product Portfolio Table 101. Portola Pharmaceuticals (US) Recent Development Table 102. Pfizer (US) Company Information Table 103. Pfizer (US) Business Overview Table 104. Pfizer (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer (US) Anticoagulants Drug Product Portfolio Table 106. Pfizer (US) Recent Development Table 107. Roche (Switzerland) Company Information Table 108. Roche (Switzerland) Business Overview Table 109. Roche (Switzerland) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Roche (Switzerland) Anticoagulants Drug Product Portfolio Table 111. Roche (Switzerland) Recent Development Table 112. Johnson & Johnson (US) Company Information Table 113. Johnson & Johnson (US) Business Overview Table 114. Johnson & Johnson (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Johnson & Johnson (US) Anticoagulants Drug Product Portfolio Table 116. Johnson & Johnson (US) Recent Development Table 117. Siemens (Germany) Company Information Table 118. Siemens (Germany) Business Overview Table 119. Siemens (Germany) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Siemens (Germany) Anticoagulants Drug Product Portfolio Table 121. Siemens (Germany) Recent Development Table 122. Abbott (US) Company Information Table 123. Abbott (US) Business Overview Table 124. Abbott (US) Anticoagulants Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Abbott (US) Anticoagulants Drug Product Portfolio Table 126. Abbott (US) Recent Development Table 127. North America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Anticoagulants Drug Sales by Country (2021-2026) & (K Units) Table 129. North America Anticoagulants Drug Sales Market Share by Country (2021-2026) Table 130. North America Anticoagulants Drug Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Anticoagulants Drug Sales Market Share Forecast by Country (2027-2032) Table 132. North America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Anticoagulants Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Anticoagulants Drug Market Share by Country (2021-2026) Table 135. North America Anticoagulants Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Anticoagulants Drug Market Share Forecast by Country (2027-2032) Table 137. Europe Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Anticoagulants Drug Sales by Country (2021-2026) & (K Units) Table 139. Europe Anticoagulants Drug Sales Market Share by Country (2021-2026) Table 140. Europe Anticoagulants Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Anticoagulants Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Anticoagulants Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Anticoagulants Drug Market Share by Country (2021-2026) Table 145. Europe Anticoagulants Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Anticoagulants Drug Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Anticoagulants Drug Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Anticoagulants Drug Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Anticoagulants Drug Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Anticoagulants Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Anticoagulants Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Anticoagulants Drug Market Share by Country (2021-2026) Table 155. Asia-Pacific Anticoagulants Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Anticoagulants Drug Market Share Forecast by Country (2027-2032) Table 157. Latin America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Anticoagulants Drug Sales by Country (2021-2026) & (K Units) Table 159. Latin America Anticoagulants Drug Sales Market Share by Country (2021-2026) Table 160. Latin America Anticoagulants Drug Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Anticoagulants Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Anticoagulants Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Anticoagulants Drug Market Share by Country (2021-2026) Table 165. Latin America Anticoagulants Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Anticoagulants Drug Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Anticoagulants Drug Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Anticoagulants Drug Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Anticoagulants Drug Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Anticoagulants Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Anticoagulants Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Anticoagulants Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Anticoagulants Drug Market Share by Country (2021-2026) Table 175. Middle East and Africa Anticoagulants Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Anticoagulants Drug Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Anticoagulants Drug Distributors List Table 180. Anticoagulants Drug Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Anticoagulants Drug Image Figure 2. Global Anticoagulants Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anticoagulants Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anticoagulants Drug Sales (2021-2032) & (K Units) Figure 5. Novel Oral Anticoagulants (NOACs) Image Figure 6. Global Novel Oral Anticoagulants (NOACs) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Warfarin (VKA) Image Figure 8. Global Warfarin (VKA) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Anticoagulants Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anticoagulants Drug Market Share by Type 2025 VS 2032 Figure 13. North America Anticoagulants Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Anticoagulants Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Anticoagulants Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anticoagulants Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anticoagulants Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anticoagulants Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anticoagulants Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anticoagulants Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anticoagulants Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anticoagulants Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anticoagulants Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Anticoagulants Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Anticoagulants Drug Market Share by Application 2025 VS 2032 Figure 33. North America Anticoagulants Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Anticoagulants Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Anticoagulants Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Anticoagulants Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Anticoagulants Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Anticoagulants Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Anticoagulants Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Anticoagulants Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Anticoagulants Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Anticoagulants Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Anticoagulants Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Anticoagulants Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Anticoagulants Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Anticoagulants Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anticoagulants Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Anticoagulants Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anticoagulants Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Anticoagulants Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anticoagulants Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Anticoagulants Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anticoagulants Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Anticoagulants Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anticoagulants Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Anticoagulants Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anticoagulants Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Anticoagulants Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anticoagulants Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Anticoagulants Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anticoagulants Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Anticoagulants Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Anticoagulants Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Anticoagulants Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Novel Oral Anticoagulants (NOACs)
  • Warfarin (VKA)
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Alere (US)
  • Bristol-Myers Squibb (US)
  • C. H. Boehringer Sohn (Germany)
  • CoaguSense (US)
  • Daiichi Sankyo (Japan)
  • Portola Pharmaceuticals (US)
  • Pfizer (US)
  • Roche (Switzerland)
  • Johnson & Johnson (US)
  • Siemens (Germany)
  • Abbott (US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anticoagulants Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anticoagulants Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anticoagulants Drug Market by Type
  6. 1.3.1 Novel Oral Anticoagulants (NOACs)
  7. 1.3.2 Warfarin (VKA)
  8. 1.3.3 Others
  9. 1.4 Global Anticoagulants Drug Market Size by Type
  10. 1.4.1 Global Anticoagulants Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anticoagulants Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anticoagulants Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anticoagulants Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anticoagulants Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anticoagulants Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anticoagulants Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anticoagulants Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anticoagulants Drug Industry Trends
  2. 2.2 Anticoagulants Drug Industry Drivers
  3. 2.3 Anticoagulants Drug Industry Opportunities and Challenges
  4. 2.4 Anticoagulants Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anticoagulants Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Anticoagulants Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Anticoagulants Drug Price (2021-2026)
  4. 3.4 Global Anticoagulants Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anticoagulants Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Anticoagulants Drug Company, Product Type & Application
  7. 3.7 Global Anticoagulants Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anticoagulants Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anticoagulants Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anticoagulants Drug Tier 1, Tier 2, and Tier 3
4 Anticoagulants Drug Regional Status and Outlook
  1. 4.1 Global Anticoagulants Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anticoagulants Drug Historic Market Size by Region
  3. 4.2.1 Global Anticoagulants Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anticoagulants Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anticoagulants Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anticoagulants Drug Forecasted Market Size by Region
  7. 4.3.1 Global Anticoagulants Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anticoagulants Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anticoagulants Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anticoagulants Drug by Application
  1. 5.1 Anticoagulants Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Anticoagulants Drug Market Size by Application
  6. 5.2.1 Global Anticoagulants Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anticoagulants Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anticoagulants Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anticoagulants Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anticoagulants Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anticoagulants Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anticoagulants Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anticoagulants Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alere (US)
  2. 6.1.1 Alere (US) Company Information
  3. 6.1.2 Alere (US) Business Overview
  4. 6.1.3 Alere (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alere (US) Anticoagulants Drug Product Portfolio
  6. 6.1.5 Alere (US) Recent Developments
  7. 6.2 Bristol-Myers Squibb (US)
  8. 6.2.1 Bristol-Myers Squibb (US) Company Information
  9. 6.2.2 Bristol-Myers Squibb (US) Business Overview
  10. 6.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb (US) Recent Developments
  13. 6.3 C. H. Boehringer Sohn (Germany)
  14. 6.3.1 C. H. Boehringer Sohn (Germany) Company Information
  15. 6.3.2 C. H. Boehringer Sohn (Germany) Business Overview
  16. 6.3.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product Portfolio
  18. 6.3.5 C. H. Boehringer Sohn (Germany) Recent Developments
  19. 6.4 CoaguSense (US)
  20. 6.4.1 CoaguSense (US) Company Information
  21. 6.4.2 CoaguSense (US) Business Overview
  22. 6.4.3 CoaguSense (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CoaguSense (US) Anticoagulants Drug Product Portfolio
  24. 6.4.5 CoaguSense (US) Recent Developments
  25. 6.5 Daiichi Sankyo (Japan)
  26. 6.5.1 Daiichi Sankyo (Japan) Company Information
  27. 6.5.2 Daiichi Sankyo (Japan) Business Overview
  28. 6.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Product Portfolio
  30. 6.5.5 Daiichi Sankyo (Japan) Recent Developments
  31. 6.6 Portola Pharmaceuticals (US)
  32. 6.6.1 Portola Pharmaceuticals (US) Company Information
  33. 6.6.2 Portola Pharmaceuticals (US) Business Overview
  34. 6.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Product Portfolio
  36. 6.6.5 Portola Pharmaceuticals (US) Recent Developments
  37. 6.7 Pfizer (US)
  38. 6.7.1 Pfizer (US) Company Information
  39. 6.7.2 Pfizer (US) Business Overview
  40. 6.7.3 Pfizer (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer (US) Anticoagulants Drug Product Portfolio
  42. 6.7.5 Pfizer (US) Recent Developments
  43. 6.8 Roche (Switzerland)
  44. 6.8.1 Roche (Switzerland) Company Information
  45. 6.8.2 Roche (Switzerland) Business Overview
  46. 6.8.3 Roche (Switzerland) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche (Switzerland) Anticoagulants Drug Product Portfolio
  48. 6.8.5 Roche (Switzerland) Recent Developments
  49. 6.9 Johnson & Johnson (US)
  50. 6.9.1 Johnson & Johnson (US) Company Information
  51. 6.9.2 Johnson & Johnson (US) Business Overview
  52. 6.9.3 Johnson & Johnson (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson (US) Anticoagulants Drug Product Portfolio
  54. 6.9.5 Johnson & Johnson (US) Recent Developments
  55. 6.10 Siemens (Germany)
  56. 6.10.1 Siemens (Germany) Company Information
  57. 6.10.2 Siemens (Germany) Business Overview
  58. 6.10.3 Siemens (Germany) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Siemens (Germany) Anticoagulants Drug Product Portfolio
  60. 6.10.5 Siemens (Germany) Recent Developments
  61. 6.11 Abbott (US)
  62. 6.11.1 Abbott (US) Company Information
  63. 6.11.2 Abbott (US) Business Overview
  64. 6.11.3 Abbott (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Abbott (US) Anticoagulants Drug Product Portfolio
  66. 6.11.5 Abbott (US) Recent Developments
7 North America by Country
  1. 7.1 North America Anticoagulants Drug Sales by Country
  2. 7.1.1 North America Anticoagulants Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anticoagulants Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Anticoagulants Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anticoagulants Drug Market Size by Country
  6. 7.2.1 North America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anticoagulants Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Anticoagulants Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anticoagulants Drug Sales by Country
  2. 8.1.1 Europe Anticoagulants Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anticoagulants Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Anticoagulants Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anticoagulants Drug Market Size by Country
  6. 8.2.1 Europe Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anticoagulants Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anticoagulants Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anticoagulants Drug Sales by Country
  2. 9.1.1 Asia-Pacific Anticoagulants Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anticoagulants Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anticoagulants Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anticoagulants Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anticoagulants Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anticoagulants Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anticoagulants Drug Sales by Country
  2. 10.1.1 South America Anticoagulants Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anticoagulants Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Anticoagulants Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anticoagulants Drug Market Size by Country
  6. 10.2.1 South America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anticoagulants Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Anticoagulants Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anticoagulants Drug Sales by Country
  2. 11.1.1 Middle East and Africa Anticoagulants Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anticoagulants Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anticoagulants Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anticoagulants Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anticoagulants Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anticoagulants Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anticoagulants Drug Value Chain Analysis
  2. 12.1.1 Anticoagulants Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anticoagulants Drug Production Mode & Process
  7. 12.2 Anticoagulants Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anticoagulants Drug Distributors
  10. 12.2.3 Anticoagulants Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst